Categories: HealthcareNews

Stryker declares a $0.80 per share quarterly dividend

Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter. 

About Stryker

Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries please contact:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com 

For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com

Staff

Recent Posts

American College of Osteopathic Family Physicians Conclave of Fellows Welcomes 2024 Class

CHICAGO, IL / ACCESSWIRE / April 5, 2024 / The American College of Osteopathic Family…

8 hours ago

Defence Therapeutics Announces Warrant Terms Amendment

Vancouver, British Columbia--(Newsfile Corp. - April 5, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…

10 hours ago

Tidepool Achieves SOC 2 Type II Compliance

PALO ALTO, Calif.--(BUSINESS WIRE)--#DiabetesData--Tidepool, a software company committed to innovations in diabetes management, is thrilled…

11 hours ago

Pathways Hospice Names Dr. Nathaniel Chappelle, M.D. as Medical Director

FORT COLLINS, CO / ACCESSWIRE / April 5, 2024 / Pathways Hospice recently named Dr.…

14 hours ago

All Care Therapies Expands Pediatric Services With Acquisition of Therapy Blocks

LAS VEGAS, NV / ACCESSWIRE / April 5, 2024 / All Care Therapies, a leading…

17 hours ago